Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (251-260 of 357) with videos related to

Pageof 36
Sort By:
Reviews in Endocrine & Metabolic Disorders|May 9, 2007
Growth factor signalling in endocrine and anti-growth factor resistant breast cancerR I Nicholson, I R Hutcheson, H E Jones, et al.
Breast Cancer Research and Treatment|October 9, 2003
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cellsIain R Hutcheson, Janice M Knowlden, Tracie-Ann Madden, et al.
Breast Cancer Research : BCR|September 24, 2011
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell linesJanice M Knowlden, Julia M W Gee, Denise Barrow, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2006
Effects of fulvestrant 250mg in premenopausal women with oestrogen receptor-positive primary breast cancerJ F R Robertson, V Semiglazov, G Nemsadze, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancerR A McClelland, J M Gee, A B Francis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?Raj S Rampaul, Sarah E Pinder, Pete M Wencyk, et al.
International Journal of Cancer|March 4, 2000
Gamma linolenic acid with tamoxifen as primary therapy in breast cancerF S Kenny, S E Pinder, I O Ellis, et al.
The Histochemical Journal|April 1, 1994
A dual immunocytochemical assay for oestrogen and epidermal growth factor receptors in tumour cell linesA K Sharma, K Horgan, R A McClelland, et al.
International Journal of Cancer|January 9, 2004
Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancerNeil K Rushmere, Janice M Knowlden, Julia M W Gee, et al.
Annals of the New York Academy of Sciences|April 30, 1996
Pure antiestrogens. The most important advance in the endocrine therapy of breast cancer since 1896R I Nicholson, J M Gee, S Bryant, et al.
Pageof 36

Showing results (251-260 of 357) with videos related to

Sort By:
Pageof 36
Reviews in Endocrine & Metabolic Disorders|May 9, 2007
Growth factor signalling in endocrine and anti-growth factor resistant breast cancerR I Nicholson, I R Hutcheson, H E Jones, et al.
Breast Cancer Research and Treatment|October 9, 2003
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cellsIain R Hutcheson, Janice M Knowlden, Tracie-Ann Madden, et al.
Breast Cancer Research : BCR|September 24, 2011
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell linesJanice M Knowlden, Julia M W Gee, Denise Barrow, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2006
Effects of fulvestrant 250mg in premenopausal women with oestrogen receptor-positive primary breast cancerJ F R Robertson, V Semiglazov, G Nemsadze, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancerR A McClelland, J M Gee, A B Francis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?Raj S Rampaul, Sarah E Pinder, Pete M Wencyk, et al.
International Journal of Cancer|March 4, 2000
Gamma linolenic acid with tamoxifen as primary therapy in breast cancerF S Kenny, S E Pinder, I O Ellis, et al.
The Histochemical Journal|April 1, 1994
A dual immunocytochemical assay for oestrogen and epidermal growth factor receptors in tumour cell linesA K Sharma, K Horgan, R A McClelland, et al.
International Journal of Cancer|January 9, 2004
Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancerNeil K Rushmere, Janice M Knowlden, Julia M W Gee, et al.
Annals of the New York Academy of Sciences|April 30, 1996
Pure antiestrogens. The most important advance in the endocrine therapy of breast cancer since 1896R I Nicholson, J M Gee, S Bryant, et al.
Pageof 36